Recent advances in hormonal contraception

F1000 Medicine Reports

Volumn 2, Issue 1, 2010, Pages

  Li, H W Raymond ^a   Anderson, Richard A ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; DIENOGEST PLUS ESTRADIOL VALERATE; DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; QLAIRA; ULIPRISNIL ACETATE; ULIPRISTAL ACETATE; UNCLASSIFIED DRUG;

AMENORRHEA; ASIAN; BONE DENSITY; BONE MINERAL; CAUCASIAN; CLINICAL PRACTICE; CONFIDENCE INTERVAL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG MARKETING; DRUG WITHDRAWAL; EMERGENCY CONTRACEPTION; FEMALE; FOLLOW UP; FRACTURE; HORMONAL CONTRACEPTION; HUMAN; LOW DRUG DOSE; MENSTRUATION DISORDER; ORAL CONTRACEPTION; OVULATION INHIBITION; PREMENSTRUAL DYSPHORIC DISORDER; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 78649370275     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-58     Document Type: Review

References (18)

1. Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ: Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study. BMJ 2010, 340:C927.
2. Endrikat JS, Milchev NP, Kapamadzija A, Georgievska J, Gerlinger C, Schmidt W, Froze S: Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada. Contraception 2009, 79:428-32.
3. Fenton C, Wellington K, Moen MD, Robinson DM: Drospirenone/ Ethinylestradiol 3mg/20[micro]g (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris. Drugs 2007, 67:1749-65.
4. Lopez LM, Kaptein AA, Helmerhorst FM: Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2009, 2:CD006586.
5. Anttila L, Kunz M, Marr J: Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Contraception 2009, 80:445-51.
6. Fruzzetti F, Bitzer J: Review of clinical experience with estradiol in combined oral contraceptives. Contraception 2010, 81:8-15.
7. Nahum GG, Parke S, Wildt L, Palacios S, Roemer T, Bitzer J: Efficacy and tolerability of a new oral contraceptive containing estradiol and dienogest. Obstet Gynecol 2008, 15S.
8. Jain J, Jakimiuk AJ, Bode FR, Ross D, Kaunitz AM: Contraceptive efficacy and safety of DMPA-SC. Contraception 2004, 70:269-75.
9. Westhoff C, Jain JK, Milsom I, Ray A: Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 ml. Contraception 2007, 75:261-7.
10. Cheng L, Gülmezoglu AM, Piaggio G, Ezcurra E, Van Look PF: Interventions for emergency contraception. Cochrane Database Syst Rev 2008, 2:CD001324.
11. Glasier AF, Cameron ST, Fine PM, Logan SJS, Casale W, van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E: Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010, 375:555-62.
12. Curtis KM, Martins SL: Progestogen-only contraception and bone mineral density: a systematic review. Contraception 2006, 73:470-87.
13. Guilbert ER, Brown JP, Kaunitz AM, Wagner MS, Berube J, Charbonneau L, Francoeur D, Gilbert A, Gilbert F, Roy G, Senikas V, Jacob R, Morin R: The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health. Contraception 2009, 79:167-77.
14. Vestergaard P, Rejnmark L, Mosekilde L: The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception 2008, 78:459-64.
15. Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L: Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density. Contraception 2009, 80:7-17.
16. Martins SL, Curtis KM, Glasier AF: Combined hormonal contraception and bone health: a systematic review. Contraception 2006, 73:445-69.
17. Pikkarainen E, Lehtonen-Veromaa M, Mottonen T, Kautiainen H, Viikari J: Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study. Contraception 2008, 78:226-31.
18. Vestergaard P, Rejnmark L, Mosekilde L: Fracture risk in very young women using combined oral contraceptives. Contraception 2008, 78:358-64.